The main shareholder of Baotou Dongbao Bio-tech (300239.SZ), China Shengyuan, has completed the reduction of 1.998% of its shares.
Dongbao Biology (300239.SZ) announced that the company's shareholder with more than 5% of the shares is Hainan Banashengyuan Technology Co., Ltd.
Baotou Dongbao Bio-tech (300239.SZ) announcement, the company's shareholder Hainan Baina Shengyuan Technology Co., Ltd. ("Baina Shengyuan") has cumulatively reduced its holdings of the company's shares by 11.86 million shares, accounting for 1.998% of the total share capital. This reduction plan has been terminated ahead of schedule.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


